• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从高血糖到细胞表面的晚期糖基化终末产物-受体相互作用:糖尿病患者的一条危险代谢途径。

From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients.

作者信息

Nogueira-Machado José Augusto, Chaves Miriam Martins

机构信息

Hospital Santa Casa de Belo Horizonte, Núcleo de Pesquisa e Pós-Graduação, Avenue Francisco Sales, 1111, 30250-330, Belo Horizonte, MG, Brazil.

出版信息

Expert Opin Ther Targets. 2008 Jul;12(7):871-82. doi: 10.1517/14728222.12.7.871.

DOI:10.1517/14728222.12.7.871
PMID:18554155
Abstract

BACKGROUND

Diabetes mellitus constitutes a serious public health problem. Recent advances in therapies are unable to control its vascular complications. New medications have been suggested but without comprehensive knowledge of the signaling pathways induced by hyperglycemia.

OBJECTIVE

To review the mechanisms of the inducer and effector phases of the metabolic cascade in diabetes, with emphasis on the steps that have been targeted to date The route from hyperglycemia to advanced glycation end products (AGE)-receptor of advanced glycation end products (RAGE) complex formation is suggested as a target for new therapies.

METHODS

A review of literature, including historical papers and recent manuscripts.

RESULTS

All the components of the suggested route are initially activated or indirectly formed due to hyperglycemia via a two-phase cascade that represents a dangerous metabolic route, especially for diabetics. Recent experiments with new drugs and clinical trials targeting this pathway are examined.

CONCLUSIONS

In order to control vascular injury in diabetes, several steps in the cascade need to be inhibited simultaneously together with aggressive glycemic control.

摘要

背景

糖尿病是一个严重的公共卫生问题。目前治疗方法的进展无法控制其血管并发症。已提出了新的药物,但对高血糖诱导的信号通路缺乏全面了解。

目的

综述糖尿病代谢级联反应诱导期和效应期的机制,重点关注迄今已作为靶点的步骤。从高血糖到晚期糖基化终产物(AGE)-晚期糖基化终产物受体(RAGE)复合物形成的途径被认为是新疗法的靶点。

方法

对文献进行综述,包括历史文献和近期手稿。

结果

所建议途径的所有成分最初都是由于高血糖通过两阶段级联反应被激活或间接形成的,这代表了一条危险的代谢途径,对糖尿病患者尤其如此。研究了针对该途径的新药近期实验和临床试验。

结论

为了控制糖尿病中的血管损伤,除了积极控制血糖外,还需要同时抑制级联反应中的几个步骤。

相似文献

1
From hyperglycemia to AGE-RAGE interaction on the cell surface: a dangerous metabolic route for diabetic patients.从高血糖到细胞表面的晚期糖基化终末产物-受体相互作用:糖尿病患者的一条危险代谢途径。
Expert Opin Ther Targets. 2008 Jul;12(7):871-82. doi: 10.1517/14728222.12.7.871.
2
Smooth muscle cell pathophysiology and advanced glycation end products (AGEs).平滑肌细胞病理生理学与晚期糖基化终产物(AGEs)。
Curr Drug Targets. 2010 Jul;11(7):875-81. doi: 10.2174/138945010791320827.
3
Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy.糖尿病视网膜病变中的晚期糖基化终末产物(AGEs)及其受体(RAGE)系统。
Curr Drug Discov Technol. 2006 Mar;3(1):83-8. doi: 10.2174/157016306776637555.
4
Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.晚期糖基化终末产物受体的激活:糖尿病血管病变和动脉粥样硬化中慢性血管功能障碍的一种机制。
Circ Res. 1999 Mar 19;84(5):489-97. doi: 10.1161/01.res.84.5.489.
5
Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications.糖尿病红细胞表面的晚期糖基化终末产物(AGEs)通过特定受体与血管壁结合,在脉管系统中诱导氧化应激:表面相关AGEs与糖尿病并发症之间的联系。
Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7742-6. doi: 10.1073/pnas.91.16.7742.
6
RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes.RAGE:糖尿病血管及炎症并发症防治的新靶点
Trends Endocrinol Metab. 2000 Nov;11(9):368-75. doi: 10.1016/s1043-2760(00)00311-8.
7
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetes.晚期糖基化终末产物受体(RAGE)与糖尿病并发症
Ageing Res Rev. 2002 Feb;1(1):1-15. doi: 10.1016/s0047-6374(01)00366-9.
8
What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose.什么是晚期糖基化终末产物受体(RAGE)?以及葡萄糖的负面影响。
Eur J Clin Invest. 1997 Mar;27(3):179-81. doi: 10.1046/j.1365-2362.1996.00072.x.
9
Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications.阻断晚期糖基化终末产物(AGE)-RAGE(AGE受体)-氧化应激系统的药物:糖尿病血管并发症的一种新型治疗策略。
Expert Opin Investig Drugs. 2008 Jul;17(7):983-96. doi: 10.1517/13543784.17.7.983.
10
Cardiovascular disease: what's all the AGE/RAGE about?心血管疾病:AGE/RAGE究竟是怎么回事?
Cardiovasc Hematol Disord Drug Targets. 2010 Mar;10(1):7-15. doi: 10.2174/187152910790780050.

引用本文的文献

1
Biochemical evaluation of novel thiazolone derivatives as dual α-glucosidase/α-amylase inhibitors, anti-inflammatory agents.新型噻唑啉酮衍生物作为双功能α-葡萄糖苷酶/α-淀粉酶抑制剂及抗炎剂的生化评价
Future Med Chem. 2025 Jan;17(2):209-219. doi: 10.1080/17568919.2024.2447225. Epub 2024 Dec 29.
2
Molecular and Functional Significance of Growth Differentiation Factor-15: A Review on Cardiovascular-Kidney-Metabolic Biomarker.生长分化因子-15的分子与功能意义:心血管-肾脏-代谢生物标志物综述
Curr Cardiol Rev. 2025 Jan 7. doi: 10.2174/011573403X332671241121063641.
3
The Multifaceted Role of the Polyphenol Curcumin: A Focus on Type 2 Diabetes Mellitus.
多酚姜黄素的多方面作用:聚焦2型糖尿病
Curr Diabetes Rev. 2025;21(8):e15733998313402. doi: 10.2174/0115733998313402240726080637.
4
Tuberculosis-diabetes comorbidities: Mechanistic insights for clinical considerations and treatment challenges.结核病-糖尿病共病:临床考量与治疗挑战的机制洞察
World J Diabetes. 2024 May 15;15(5):853-866. doi: 10.4239/wjd.v15.i5.853.
5
Diabetes and high-glucose could upregulate the expression of receptor for activated C kinase 1 in retina.糖尿病和高血糖可上调视网膜中活化C激酶1受体的表达。
World J Diabetes. 2024 Mar 15;15(3):519-529. doi: 10.4239/wjd.v15.i3.519.
6
Galectin-3 Mediates Vascular Dysfunction in Obesity by Regulating NADPH Oxidase 1.半乳糖凝集素-3 通过调节 NADPH 氧化酶 1 介导肥胖中的血管功能障碍。
Arterioscler Thromb Vasc Biol. 2023 Oct;43(10):e381-e395. doi: 10.1161/ATVBAHA.123.319476. Epub 2023 Aug 10.
7
Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities.新型1,3,5-三取代-2-硫代咪唑烷-4-酮类似物的抗糖尿病潜力:对α-葡萄糖苷酶、α-淀粉酶及抗氧化活性的深入研究
Pharmaceuticals (Basel). 2022 Dec 17;15(12):1576. doi: 10.3390/ph15121576.
8
Neuropharmacological and Antidiabetic Potential of (Houtt.) Merr. Leaves Extract: An Experimental Analysis.(虎耳草科植物)梅叶提取物的神经药理学和抗糖尿病潜力:一项实验分析
Evid Based Complement Alternat Med. 2022 Mar 28;2022:6144733. doi: 10.1155/2022/6144733. eCollection 2022.
9
Stimulation of Alpha-1-Adrenergic Receptor Ameliorates Obesity-Induced Cataracts by Activating Glycolysis and Inhibiting Cataract-Inducing Factors.刺激 Alpha-1-肾上腺素能受体通过激活糖酵解和抑制白内障诱导因素来改善肥胖诱导的白内障。
Endocrinol Metab (Seoul). 2022 Apr;37(2):221-232. doi: 10.3803/EnM.2021.1237. Epub 2022 Mar 23.
10
Endothelial Dysfunction: An Intermediate Clinical Feature between Urolithiasis and Cardiovascular Diseases.内皮功能障碍:尿石症与心血管疾病之间的中间临床特征。
Int J Mol Sci. 2022 Jan 14;23(2):912. doi: 10.3390/ijms23020912.